Related Experiment Video
Updated: May 21, 2026
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Osteosarcoma Phenotype Is Inhibited by 3,4-Methylenedioxy-β-nitrostyrene
Patrick J Messerschmitt1, Ashley N Rettew, Nicholas O Schroeder
1Department of Orthopaedics, University Hospitals Case Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106, USA.
Abstract:
β-nitrostyrene compounds, such as 3,4-methylenedioxy-β-nitrostyrene (MNS), inhibit growth and induce apoptosis in tumor cells, but no reports have investigated their role in osteosarcoma. In this study, human osteosarcoma cell families with cell lines of varying tumorigenic and metastatic potential were utilized. Scrape motility assays, colony formation assays, and colony survival assays were performed with osteosarcoma cell lines, both in the presence and absence of MNS. Effects of MNS on human osteoblasts and airway epithelial cells were assessed in monolayer cultures. MNS decreased metastatic cell line motility by 72-76% and colony formation by 95-100%. MNS consistently disrupted preformed colonies in a time-dependent and dose-dependent manner. MNS had similar effects on human osteoblasts but little effect on airway epithelial cells. An inactive analog of MNS had no detectable effects, demonstrating specificity. MNS decreases motility and colony formation of osteosarcoma cells and disrupts preformed cell colonies, while producing little effect on pulmonary epithelial cells.
Insights
3,4-methylenedioxy-β-nitrostyrene (MNS) significantly inhibits osteosarcoma cell motility and colony formation. This compound also disrupts existing tumor cell colonies, showing potential as an anti-cancer agent.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- β-nitrostyrene compounds show anti-tumor properties.
- Their effect on osteosarcoma remains unexplored.
Purpose of the Study:
- Investigate the effects of 3,4-methylenedioxy-β-nitrostyrene (MNS) on human osteosarcoma cells.
- Assess MNS's impact on cell motility, colony formation, and survival.
Main Methods:
- Utilized human osteosarcoma cell lines with varying metastatic potential.
- Performed scrape motility, colony formation, and colony survival assays.
- Assessed MNS effects on human osteoblasts and airway epithelial cells.
Main Results:
- MNS reduced metastatic osteosarcoma cell motility by 72-76%.
- MNS inhibited colony formation by 95-100% and disrupted preformed colonies.
- MNS affected osteoblasts similarly but had minimal impact on airway epithelial cells.
- Specificity was confirmed using an inactive MNS analog.
Conclusions:
- MNS demonstrates significant anti-cancer activity against osteosarcoma cells.
- MNS effectively reduces cell motility and colony formation.
- MNS exhibits specificity, with minimal effects on normal pulmonary epithelial cells.
